Evidence supporting that the attribution of first success in use of arsenic for the treatment of leukaemia should be to David Lissauer (1836–1892)
Crossref DOI link: https://doi.org/10.1038/s41375-022-01608-y
Published Online: 2022-05-19
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Manley, Paul W. https://orcid.org/0000-0002-9722-7863
Text and Data Mining valid from 2022-05-19
Version of Record valid from 2022-05-19
Article History
Received: 22 April 2022
Revised: 11 May 2022
Accepted: 12 May 2022
First Online: 19 May 2022
Competing interests
: PWM is an employee of Novartis Pharma AG, Basel, Switzerland.